David Gerring

David Gerring is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of injection systems for insulin delivery. With a total of 7 patents to his name, Gerring's work has had a meaningful impact on medical practices.

Latest Patents

One of Gerring's latest patents is an injection pen system designed for the delivery of an insulin compound. This innovative system includes an injector mechanism and a reservoir containing an aqueous liquid pharmaceutical composition. The composition is specifically formulated to include an insulin compound, ionic zinc, and an alkyl glycoside as a non-ionic surfactant. Another notable patent involves an aqueous solution composition with a pH range of 6.0 to 8.0. This composition comprises daptomycin or its analogues, a divalent metal cation, and various salts at a total concentration of 300 mM or more.

Career Highlights

Throughout his career, David Gerring has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Arecor Limited and Fresenius Kabi Deutschland GmbH. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug delivery systems.

Collaborations

Gerring has collaborated with several professionals in his field, including Jan Jezek and Luca Badiali. These collaborations have fostered a creative environment that has led to the development of groundbreaking technologies in pharmaceutical applications.

Conclusion

David Gerring's contributions to the field of pharmaceutical technology are noteworthy. His innovative patents and collaborations have significantly advanced the methods of drug delivery, particularly in insulin administration. His work continues to influence the industry and improve patient care.

This text is generated by artificial intelligence and may not be accurate.